RE: NXP00229 Jan 2025 06:44
According to available data, the worldwide treatment cost for Idiopathic Pulmonary Fibrosis (IPF) can range significantly, but generally falls around $100,000 per patient per year due to the high cost of primary treatment medications like nintedanib and pirfenidone, with additional costs associated with hospitalizations, monitoring, and other related healthcare needs; this cost can vary significantly depending on location and healthcare system access.